Inflammatory Bowel Disease (IBD), encompassing Crohn's disease and ulcerative colitis, is characterized by chronic inflammation of the gastrointestinal tract. Traditional treatments often fall short in providing complete symptom relief, leading some patients to explore alternative therapies, including medical cannabis. Clinical Evidence Recent studies have investigated the potential benefits of cannabis in managing IBD symptoms: Symptom Relief: A 2019 prospective observational study assessed the effects of licensed cannabis use among 127 IBD patients.
The study found that us cannabis prices use led to clinical improvement, reduced medication use, and slight weight gain, without negative effects on patients' social or occupational status. LIPPINCOTT JOURNALS Quality of Life: A 2022 analysis from the UK Medical Cannabis Registry evaluated health-related quality of life (HRQoL) and adverse events in IBD patients prescribed cannabis-based medicinal products (CBMPs).
